搜索





搜索





市场行情
/
股票
/
dnli
/

Denali Therapeutics Inc

DNLI

添加自选

24.040USD

+0.470+1.99%

收盘 07-28 16:00（美东）报价延迟15分钟

3.81B总市值

亏损市盈率 TTM

Denali Therapeutics Inc

24.040

+0.470+1.99%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

DNLI 利润表

您可以在这里找到Denali Therapeutics Inc的年度或季度收入报告，以深入了解Denali Therapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

营业总收入

----

--0.00

----

--0.00

-100.00%0.00

-64.40%1.27M

460.45%294.12M

-16.61%35.14M

-17.83%10.28M

-32.66%3.56M

128.78%52.48M

431.88%42.14M

-96.05%12.51M

-43.73%5.29M

292.32%22.94M

119.84%7.92M

6681.14%316.81M

-30.95%9.39M

39.31%5.85M

-14.29%3.60M

-96.28%4.67M

1038.41%13.60M

154.67%4.20M

556.01%4.21M

--125.68M

--1.20M

--1.65M

--641.00K

----

--0.00

----

营业收入

----

--0.00

----

--0.00

-100.00%0.00

-64.40%1.27M

460.45%294.12M

-16.61%35.14M

-17.83%10.28M

-32.66%3.56M

128.78%52.48M

431.88%42.14M

-96.05%12.51M

-43.73%5.29M

292.32%22.94M

119.84%7.92M

6681.14%316.81M

-30.95%9.39M

39.31%5.85M

-14.29%3.60M

-96.28%4.67M

1038.41%13.60M

154.67%4.20M

556.01%4.21M

--125.68M

--1.20M

--1.65M

--641.00K

----

--0.00

----

营业费用

-5.65%137.36M

5.79%137.37M

11.57%137.43M

15.76%134.96M

10.08%145.58M

-2.06%129.85M

7.06%123.19M

-5.70%116.59M

-15.20%132.25M

14.65%132.57M

3.62%115.06M

8.56%123.64M

43.55%155.96M

29.00%115.63M

22.19%111.05M

34.38%113.90M

37.27%108.64M

23.23%89.64M

30.74%90.88M

26.27%84.76M

24.50%79.14M

16.51%72.74M

9.02%69.51M

0.24%67.12M

36.09%63.57M

22.52%62.43M

62.82%63.76M

13.43%66.96M

77.02%46.71M

116.46%50.95M

75.70%39.16M

161.57%59.03M

21.36%26.39M

19.03%23.54M

-27.95%22.29M

--22.57M

--21.74M

--19.78M

--30.93M

研发费用

-10.65%103.85M

-1.89%97.91M

3.78%101.95M

12.36%102.70M

8.61%116.23M

-7.44%99.79M

9.47%98.24M

-6.28%91.40M

-16.92%107.02M

17.04%107.80M

2.22%89.74M

5.16%97.52M

49.62%128.82M

35.70%92.11M

22.68%87.79M

41.13%92.74M

43.00%86.10M

23.99%67.88M

33.25%71.56M

23.63%65.71M

18.02%60.21M

6.19%54.74M

2.21%53.70M

2.44%53.15M

36.40%51.02M

29.17%51.55M

73.29%52.54M

-0.48%51.88M

79.66%37.40M

116.06%39.91M

63.76%30.32M

174.33%52.13M

12.72%20.82M

10.41%18.47M

-33.44%18.52M

--19.00M

--18.47M

--16.73M

--27.82M

折旧摊销及损耗

17.09%3.76M

44.41%3.78M

70.21%3.86M

103.71%3.96M

48.57%3.21M

20.30%2.62M

2.35%2.27M

-15.01%1.94M

-78.48%2.16M

-46.79%2.18M

3.55%2.22M

10.28%2.29M

383.26%10.05M

95.37%4.09M

-2.10%2.14M

-5.99%2.07M

-1.38%2.08M

-1.27%2.09M

1.44%2.19M

2.75%2.20M

-0.05%2.11M

3.21%2.12M

14.07%2.16M

30.55%2.15M

-12.23%2.11M

-13.62%2.06M

-18.78%1.89M

-11.43%1.64M

181.38%2.40M

194.80%2.38M

199.10%2.33M

142.17%1.85M

16.83%854.00K

17.64%807.00K

94.01%778.00K

--766.00K

--731.00K

--686.00K

--401.00K

营业利润

5.65%-137.36M

-5.79%-137.37M

-11.57%-137.43M

-15.76%-134.96M

-10.08%-145.58M

2.06%-129.85M

-8.25%-123.19M

-168.39%-116.59M

-9.47%-132.25M

-25.85%-132.57M

-5.87%-113.80M

377.59%170.48M

-81.68%-120.81M

-36.60%-105.34M

-25.58%-107.49M

0.65%-61.42M

6.63%-66.50M

-131.60%-77.12M

-42.38%-85.59M

-0.88%-61.82M

-18.77%-71.22M

522.59%244.08M

-19.86%-60.12M

2.37%-61.28M

-41.07%-59.97M

-177.30%-57.76M

-32.11%-50.16M

-9.38%-62.76M

-65.09%-42.51M

417.43%74.72M

-70.33%-37.96M

-154.26%-57.38M

-18.41%-25.75M

-19.03%-23.54M

27.95%-22.29M

---22.57M

---21.74M

---19.78M

---30.93M

净非营业利息收入（费用）

利息收入

-29.05%9.09M

-40.51%9.14M

-33.32%10.73M

--11.04M

--12.81M

--15.36M

--16.09M

----

利息费用

-10.50%179.00K

10.00%220.00K

100.00%200.00K

--200.00K

--100.00K

----

特殊收入（费用）

----

--0.00

-100.00%0.00

--0.00

--14.54M

----

税前利润

3.40%-128.45M

-12.00%-128.45M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.98%-114.69M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.04%-119.44M

3.82%-99.35M

412.05%183.38M

-68.32%-109.78M

-30.13%-98.68M

-22.12%-103.30M

3.17%-58.77M

6.88%-65.22M

-130.86%-75.84M

-45.41%-84.59M

-3.43%-60.69M

-23.10%-70.04M

555.44%245.71M

-25.44%-58.17M

-0.05%-58.68M

-45.92%-56.90M

-169.58%-53.95M

-31.10%-46.37M

-7.17%-58.65M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

所得税

----

50.00%102.00K

----

126.67%68.00K

----

600.00%30.00K

--0.00

-100.00%0.00

----

98.96%-6.00K

--0.00

--27.00K

----

-169.87%-575.00K

-100.00%0.00

100.00%0.00

997.33%823.00K

149.56%56.00K

125.24%79.00K

---135.00K

--75.00K

---113.00K

---313.00K

----

除税后利润

3.40%-128.45M

-12.02%-128.55M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.07%-119.47M

3.82%-99.35M

411.91%183.38M

-68.32%-109.78M

-31.11%-98.68M

-22.12%-103.30M

3.13%-58.79M

6.88%-65.22M

-130.73%-75.26M

-45.27%-84.59M

-3.29%-60.69M

-23.39%-70.04M

553.28%244.88M

-25.87%-58.23M

-0.72%-58.76M

-45.58%-56.76M

-169.68%-54.02M

-30.79%-46.26M

-6.60%-58.34M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

持续经营利润

3.40%-128.45M

-12.02%-128.55M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.07%-119.47M

3.82%-99.35M

411.91%183.38M

-68.32%-109.78M

-31.11%-98.68M

-22.12%-103.30M

3.13%-58.79M

6.88%-65.22M

-130.73%-75.26M

-45.27%-84.59M

-3.29%-60.69M

-23.39%-70.04M

553.28%244.88M

-25.87%-58.23M

-0.72%-58.76M

-45.58%-56.76M

-169.68%-54.02M

-30.79%-46.26M

-6.60%-58.34M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

归属于母公司的净利润

3.40%-128.45M

-12.02%-128.55M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.07%-119.47M

3.82%-99.35M

411.91%183.38M

-68.32%-109.78M

-31.11%-98.68M

-22.12%-103.30M

3.13%-58.79M

6.88%-65.22M

-130.73%-75.26M

-45.27%-84.59M

-3.29%-60.69M

-23.39%-70.04M

553.28%244.88M

-25.87%-58.23M

-0.72%-58.76M

-45.58%-56.76M

-169.68%-54.02M

-30.79%-46.26M

-6.60%-58.34M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

归属于普通股东的净利润

3.40%-128.45M

-12.02%-128.55M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.07%-119.47M

3.82%-99.35M

411.91%183.38M

-68.32%-109.78M

-31.11%-98.68M

-22.12%-103.30M

3.13%-58.79M

6.88%-65.22M

-130.73%-75.26M

-45.27%-84.59M

-3.29%-60.69M

-23.39%-70.04M

553.28%244.88M

-25.87%-58.23M

-0.72%-58.76M

-45.58%-56.76M

-169.68%-54.02M

-30.79%-46.26M

-6.60%-58.34M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

基本每股收益

11.38%-0.69

-8.60%-0.73

-16.35%-0.74

-23.43%-0.72

-13.97%-0.78

21.95%-0.67

12.36%-0.63

-143.83%-0.59

15.26%-0.68

-16.44%-0.86

13.72%-0.72

379.95%1.34

-51.25%-0.80

-20.48%-0.74

-20.41%-0.84

4.48%-0.48

8.24%-0.53

-130.25%-0.62

-28.26%-0.69

9.97%-0.50

-4.54%-0.58

462.21%2.04

-12.25%-0.54

9.02%-0.56

-35.01%-0.55

-168.40%-0.56

-27.79%-0.48

-3.70%-0.61

-55.27%-0.41

468.69%0.82

-42.49%-0.38

74.26%-0.59

88.82%-0.26

5.05%-0.22

28.64%-0.27

---2.29

---2.36

---0.23

---0.37

稀释每股收益

11.38%-0.69

-8.60%-0.73

-16.35%-0.74

-23.43%-0.72

-13.97%-0.78

21.95%-0.67

12.36%-0.63

-145.08%-0.59

15.26%-0.68

-16.44%-0.86

13.72%-0.72

372.24%1.30

-51.25%-0.80

-20.48%-0.74

-20.41%-0.84

4.48%-0.48

8.24%-0.53

-134.00%-0.62

-28.26%-0.69

9.97%-0.50

-4.54%-0.58

422.23%1.81

-12.25%-0.54

9.02%-0.56

-35.01%-0.55

-168.40%-0.56

-27.79%-0.48

-3.70%-0.61

-55.27%-0.41

468.69%0.82

-42.49%-0.38

74.26%-0.59

88.82%-0.26

5.05%-0.22

28.64%-0.27

---2.29

---2.36

---0.23

---0.37

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Denali Therapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 DNLI 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Denali Therapeutics Inc 全年的净利润是多少？



Denali Therapeutics Inc 2025 财年净利润为 -512.54M。

Denali Therapeutics Inc 上一季度的净利润是多少？



Denali Therapeutics Inc 最近一个季度的净利润为 -128.45M。

Denali Therapeutics Inc 年度营业利润是多少？



Denali Therapeutics Inc 2025 财年的营业利润为 -555.34M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。